Back to search

France· FR:67169242

ALTEISDUO 40 mg/12,5 mg, comprimé pelliculé

A medicinal product containing hydrochlorothiazide + olmésartan médoxomil, registered in France by MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG.

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedALTEISDUO 40 mg/12,5 mg, comprimé pel…ATC—REGISTER NO.FR:67169242PACKS LISTED1CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
HYDROCHLOROTHIAZIDE + OLMÉSARTAN MÉDOXOMIL
Manufacturer
MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG
Country
France (FR)
ATC code
—
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400935023865
    plaquette(s) polyamide aluminium PVC-Aluminium de 30 comprimé(s)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Hydrochlorothiazide + olmésartan médoxomil in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All hydrochlorothiazide + olmésartan médoxomil products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

  • Austria · Mencord Plus, Olmeblo Hct
  • Belgium · Belsar Plus, Co-Olmesartan
  • Bulgaria · Olmesartan/Hctz Mylan, Ко-Олиместра
  • Cyprus · Olartan-Plus, Olmesartan/Hydrochlorothiazide Tad
  • Czechia · Sarten Plus H, Zeota Hct
  • Germany · Olmecor Hct, Olmes Plus
  • Denmark · Olmesartan Medoxomil/Hydrochlorothiazide Krka
  • Estonia · Co-Olimestra, Mesar Plus
  • Spain · Atolme Plus, Ixia Plus
  • Finland · Olmesartan Medoxomil/Hydrochlorothiazide Krka
  • United Kingdom (Northern Ireland) · Olmesartan Medoxomil/Hydrochlorothiazide Accord Healthcare, Olmesartan Medoxomil/Hydrochlorothiazide Msn Laboratories Europe
  • Greece · Co-Ipertas, Olartan-Plus
  • Croatia · Co-Olimestra, Olmesartan/Hidroklorotiazid Genericon
  • Hungary · Laresin Plus
  • Ireland · Olmesartan/Hydrochlorothiazide Clonmel, Olmesartan/Hydrochlorothiazide Krka
  • Italy · Idalazide, Olmegan
  • Lithuania · Co-Olimestra, Mesar Plus
  • Luxembourg · Belsar Plus, Olmesartan Plus Hct
  • Latvia · Co-Olimestra, Mesar Plus
  • Malta · Olmesartan Medoxomil/Hydrochlorothiazide Msn, Olmesartan/ Hydrochlorothiazide Msn
  • Netherlands · Hydrochlorothiazide/ Olmesartan Medoxomil Aurobindo, Hydrochlorothiazide/Olmesartan Medoxomil Aurobindo
  • Norway · Olmesartan Medoxomil/Hydrochlorothiazide Krka
  • Poland · Co-Olimestra, Osaver Hct
  • Portugal · Olmesartan + Hidroclorotiazida Sandoz, Olmesartan Medoxomilo + Hidroclorotiazida Alter
  • Slovenia · Co-Tensiol, Olmicombi
  • Slovakia · Tenzar Plus

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/bd851251-1441-40ed-b91c-e96d58edaa13
GET /v1/drugs/bd851251-1441-40ed-b91c-e96d58edaa13?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "67169242",
  "date_amm": "2010-03-10",
  "type_amm": "Procédure décentralisée",
  "numero_ue": null,
  "substance": "HYDROCHLOROTHIAZIDE + OLMÉSARTAN MÉDOXOMIL",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé pelliculé",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about hydrochlorothiazide + olmésartan médoxomil.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.